← Back to Search

Intervention for Cancer

N/A

Waitlist Available

Led By Claudia M Dourado, MD

Research Sponsored by Albert Einstein Healthcare Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will study how well patients with low literacy and poor socio-economic status adhere to oral anticancer agents.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to oral chemotherapy

Secondary outcome measures

Adherence to scheduled follow-up medical care visits

Frequency of medication refills

Healthcare utilization

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

In addition to the standard of care, the participants randomized to Intervention Group will be invited to a separate room. The following activities will be undertaken, in order to address patients' questions and concerns, and discuss potential solutions to their barriers to care The patient will be asked to watch brief educational videos on "Life with oral cancer treatment." The information contained in the videos will be reinforced with materials written at a 4th grade level, that correspond to each of the brief videos.The patient will receive a brief phone call (from the study coordinator) on the first business day following the baseline interview, and thereafter, two weeks following each visit to the oncology clinic.

Group II: Standard of Care (Control Group)Active Control1 Intervention

All participants in this group will receive the standard of care intervention provided by the RN.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intervention

2011

Completed Phase 4

~73780

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Merck Sharp & Dohme LLCIndustry Sponsor

3,886 Previous Clinical Trials

5,054,461 Total Patients Enrolled

Albert Einstein Healthcare NetworkLead Sponsor

63 Previous Clinical Trials

868,512 Total Patients Enrolled

Claudia M Dourado, MDPrincipal InvestigatorAlbert Einstein Healthcare Network

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently recruiting participants?

"This clinical trial is currently in search of test subjects, according to the information available on clinicialtrials.gov. It was originally posted on July 20th 2017 and has been recently updated as of December 7th 2021."

Answered by AI

How many volunteers have enrolled in this research endeavor?

"Indeed, clinicaltrials.gov confirms that this medical study is currently accepting participants. This trial was initially posted on July 20th 2017 and recently revised on December 7th 2021. The clinical trial has the capacity to enrol 110 patients across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Claudia Dourado,MD 2017. "Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03245411.